日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center

质子治疗局部前列腺癌的毒性结果:综合癌症中心的长期结果

Sosa, Alan J; Rooney, Michael K; Thames, Howard D; Sanders, Jeremiah W; Swanson, David M; Choi, Seungtaek L; Nguyen, Quynh-Nhu; Mok, Henry; Kuban, Deborah A; Ron Zhu, X; Shah, Shalin; Mayo, Lauren L; Hoffman, Karen E; Tang, Chad; McGuire, Sean E; Sahoo, Narayan; Zhang, Xiaodong; Lee, Andrew K; Pugh, Thomas J; Mahmood, Usama; Davis, John W; Chapin, Brian F; Corn, Paul; Kudchadker, Reena; Ausat, Noveen; Frank, Steven J

Prospective Evaluation of Prostate and Organs at Risk Segmentation Software for MRI-based Prostate Radiation Therapy

前瞻性评估基于磁共振成像的前列腺放射治疗中前列腺及危及器官分割软件

Sanders, Jeremiah W; Kudchadker, Rajat J; Tang, Chad; Mok, Henry; Venkatesan, Aradhana M; Thames, Howard D; Frank, Steven J

Sample-size calculation for preclinical dose-response experiments using heterogeneous tumour models

利用异质性肿瘤模型进行临床前剂量反应实验的样本量计算

Ciecior, Willy; Ebert, Nadja; Borgeaud, Nathalie; Thames, Howard D; Baumann, Michael; Krause, Mechthild; Löck, Steffen

Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis

消融性放射治疗剂量可显著延长无法手术切除的肝内胆管癌患者的生存期:一项回顾性剂量反应分析

Tao, Randa; Krishnan, Sunil; Bhosale, Priya R; Javle, Milind M; Aloia, Thomas A; Shroff, Rachna T; Kaseb, Ahmed O; Bishop, Andrew J; Swanick, Cameron W; Koay, Eugene J; Thames, Howard D; Hong, Theodore S; Das, Prajnan; Crane, Christopher H

Computational Modeling of Micrometastatic Breast Cancer Radiation Dose Response

微转移性乳腺癌放射剂量反应的计算模型

Smith, Daniel L; Debeb, Bisrat G; Thames, Howard D; Woodward, Wendy A

The Limitations of Model-Based Experimental Design and Parameter Estimation in Sloppy Systems

模型驱动实验设计和参数估计在不规则系统中的局限性

White, Andrew; Tolman, Malachi; Thames, Howard D; Withers, Hubert Rodney; Mason, Kathy A; Transtrum, Mark K

Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses

放射治疗肿瘤学组9003号方案最终报告:探索性分析得出的结论引人深思,但存在局限性

Rosenthal, David I; Fuller, Clifton D; Peters, Lester J; Thames, Howard D Jr

A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancer.

高含量克隆形成存活药物筛选发现,MEK 抑制剂是 KRAS 突变型非小细胞肺癌的有效放射增敏剂

Lin Steven H, Zhang Jing, Giri Uma, Stephan Clifford, Sobieski Mary, Zhong Ling, Mason Kathy A, Molkentine Jessica, Thames Howard D, Yoo Stephen S, Heymach John V

Estimation of α/β for late rectal toxicity based on RTOG 94-06

基于 RTOG 94-06 的晚期直肠毒性 α/β 值估计

Tucker, Susan L; Thames, Howard D; Michalski, Jeff M; Bosch, Walter R; Mohan, Radhe; Winter, Kathryn; Cox, James D; Purdy, James A; Dong, Lei

Ultraviolet A does not induce melanomas in a Xiphophorus hybrid fish model

紫外线A不会在剑尾鱼杂交鱼模型中诱发黑色素瘤。

Mitchell, David L; Fernandez, André A; Nairn, Rodney S; Garcia, Rachel; Paniker, Lakshmi; Trono, David; Thames, Howard D; Gimenez-Conti, Irma